Page last updated: 2024-11-07

epsilon-hydroxynorleucine, (l)-isomer

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

epsilon-hydroxynorleucine: RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID97725
CHEMBL ID1233976
SCHEMBL ID128663
MeSH IDM0307625

Synonyms (44)

Synonym
CHEMBL1233976
nsc-16535
6-hydroxynorleucine
epsilon-hydroxynorleucine
l-norleucine, 6-hydroxy-
nsc-206290
6033-32-5
l-2-amino-6-hydroxyhexanoic acid
NCGC00013214
6-hydroxy-l-norleucine
alpha-amino-epsilon-hydroxycaproic acid
2-amino-6-hydroxycaproic acid
DB03412
NCI16535
NCISTRUC1_001900
NCISTRUC2_000242
NCGC00096335-01
l-6-hydroxynorleucine
(2s)-2-amino-6-hydroxyhexanoic acid
AKOS006275214
nsc 16535
nsc 206290
874d12o72w ,
unii-874d12o72w
(s)-2-amino-6-hydroxyhexanoic acid
epsilon-hydroxy-l-norleucine
nsc 32041
CCG-37660
NCGC00013214-02
SCHEMBL128663
(s)-2-amino-6-hydroxy-hexanoic acid
OLUWXTFAPJJWPL-YFKPBYRVSA-N
mfcd00211279
l-6-hydroxynorleucine (h-l-nle(oh)-oh)
(+)-l-.epsilon.-hydroxynorleucine
l-6-hydroxy norleucine
CS-0266479
Q27096308
A917885
F79797
(s)-2-amino-6-hydroxyhexanoicacid
EN300-222084
PD007011
dl-6-hydroxynorleucine
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (66.67)18.7374
1990's1 (11.11)18.2507
2000's1 (11.11)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.05 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.36 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]